Lilly to boost diabetes sales force

Share this article:
Eli Lilly said it expects to increase its diabetes sales force by 40% in 2007. The move comes as Lilly plans launch five new insulin pen delivery products and bolster efforts behind its recently launched diabetes treatment Byetta, Lilly president John Lechleiter told investors last Thursday. Byetta’s new-prescription volume increased 30% over the last month, Lilly said. The drug also recently won approval to be marketed in Europe.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.